Grady Memorial Hospital, frequently referred to as Grady Hospital or simply Grady, is the public hospital for the city of Atlanta. It is the fifth-largest public hospital in the United States, and one of the busiest Level I trauma centers in the country.

There are 961 beds in Emory University; Grady Memorial Hospital.

During the past decade, Emory University; Grady Memorial Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 6 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Emory University; Grady Memorial Hospital" #1 sponsor was "Stryker Neurovascular" with 3 trials, followed by "BrainScope Company, Inc." with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "AIDS Malignancy Consortium" with 1 trials sponsored and "Alessandro Doria" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Emory University; Grady Memorial Hospital" #1 collaborator was "Albert Einstein College of Medicine" with 2 trials as a collaborator, "Emory University" with 2 trials as a collaborator, "Northwestern University Feinberg School of Medicine" with 2 trials as a collaborator, "University of Colorado, Denver" with 2 trials as a collaborator and "University of Michigan" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Emory University; Grady Memorial Hospital" are "Ischemic Stroke" (3 trials), "Brain Injuries" (2 trials), "Diabetic Nephropathies" (2 trials), "Type 2 Diabetes" (2 trials) and "Acute Stroke" (1 trials). Many other conditions were trialed in "Emory University; Grady Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Emory University; Grady Memorial Hospital" are "Device" (7 trials), "Drug" (7 trials), "Other" (7 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Allopurinol" (2 trials), "BrainScope Ahead 200" (2 trials), "Tirzepatide" (2 trials) and "% time 70-180 mg/dL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Emory University; Grady Memorial Hospital" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Emory University; Grady Memorial Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Emory University; Grady Memorial Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Emory University; Grady Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".